Financial Gravity Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Financial Gravity Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.79K	Buy	+4	New	+$1.86K	﹤0.01%	722
2024 Q2	–	Sell	-7	Closed	-$2.93K	–	1788
2024 Q1	$2.93K	Sell	7 -5	-42%	-$2.11K	﹤0.01%	649
2023 Q4	$5.13K	Buy	+12	New	+$4.43K	﹤0.01%	590
2021 Q3	$181K	Hold	7	–	–	0.09%	206
2021 Q2	$202K	Buy	+7	New	+$1.46K	0.07%	187
2020 Q4	$10K	Buy	+44	New	+$10.1K	0.01%	181
2019 Q4	$219K	Sell	503 -251	-33%	-$50.8K	0.15%	99
2019 Q3	$128K	Sell	754 -167	-18%	-$29.5K	0.11%	175
2019 Q2	$169K	Sell	921 -197	-18%	-$34.4K	0.14%	165
2019 Q1	$208K	Buy	+1,118	New	+$206K	0.17%	131
2018 Q3	$227K	Buy	1,334 +214	+19%	+$38.1K	0.24%	95
2018 Q2	$196K	Sell	1,120 -96	-8%	-$14.9K	0.18%	117
2018 Q1	$182K	Buy	+1,216	New	+$199K	0.19%	107

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Financial Gravity Asset Management's VRTX Position: Q1 2026 in Review

Financial Gravity Asset Management opened a new position in Vertex Pharmaceuticals (VRTX) in Q1 2026: 4 shares worth $1.79K. The stake represents ﹤0.01% of the portfolio and ranks #722 among its holdings. This is a return to the name: Financial Gravity Asset Management previously reported a position in VRTX as recently as Q1 2024.

Financial Gravity Asset Management first reported a position in VRTX in Q1 2018 and has held it in 13 quarters since. The position peaked at $227K in Q3 2018. 1,699 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Financial Gravity Asset Management held 4 shares of Vertex Pharmaceuticals worth $1.79K as of Q1 2026.
Vertex Pharmaceuticals was a new Financial Gravity Asset Management position in Q1 2026.
Vertex Pharmaceuticals made up ﹤0.01% of Financial Gravity Asset Management's portfolio in Q1 2026, its #722 holding.
Financial Gravity Asset Management first reported a position in Vertex Pharmaceuticals in Q1 2018 and has held it in 13 quarters since.
Financial Gravity Asset Management's Vertex Pharmaceuticals position peaked at $227K in Q3 2018.
1,699 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Financial Gravity Asset Management's 13F filing for Q1 2026, filed 8 May 2026.